000 01402 a2200349 4500
005 20250514163421.0
264 0 _c20040408
008 200404s 0 0 eng d
022 _a1048-891X
024 7 _a10.1111/j.1525-1438.2003.13365.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPecorelli, S
245 0 0 _aConsolidation therapies revisited: weekly paclitaxel.
_h[electronic resource]
260 _bInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
_c
300 _a208-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aDisease-Free Survival
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
_xadministration & dosage
650 0 4 _aProspective Studies
650 0 4 _aSurvival Analysis
700 1 _aOdicino, F
700 1 _aFavalli, G
773 0 _tInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
_gvol. 13 Suppl 2
_gp. 208-11
856 4 0 _uhttps://doi.org/10.1111/j.1525-1438.2003.13365.x
_zAvailable from publisher's website
999 _c14390386
_d14390386